SOURCE: ALR Technologies Inc.

August 31, 2005 07:00 ET

ALR Technologies Reaches Product Development Milestones With Their Disease Management Home Monitoring System

CEO Sidney Chan Optimistic About Sales and Earnings in 2006

WINSTON-SALEM, NC -- (MARKET WIRE) -- August 31, 2005 -- ALR Technologies Inc. (OTC BB: ALRT), headquartered in Winston-Salem, NC, announces today they have reached significant milestones in development of their disease management home monitoring system. The company reports the pilot program for the monitoring system will commence in September 2005. The company also announced they are moving forward on their plans to add diagnostic monitoring to their home monitoring system. This will enable medical personnel or other caregivers to remotely monitor on a daily basis such key data as blood pressure, blood glucose, heart rate and use of nebulizer compressors.

ALR Tech's PC500 Disease Management Reminder Product has been in trial usage, and now with the addition of the monitoring system the benefit to patients and healthcare providers is extended. The PC500 reminder product helps people to be compliant with medication or treatment regimens, and the monitoring system allows medical service providers to monitor the patient's compliance with these regimens. This "real time" identification of noncompliance allows for timely intervention when deemed necessary.

ALR, which plans to begin shipping commercial product in late first quarter of 2006, will manage initial supply and manufacturing by first targeting patient population groups: specifically chronic obstructive pulmonary disease (COPD), mental disorders (schizophrenia, obsessive compulsive disorder and bipolar), Organ transplantation and HIV/AIDS.

Sidney Chan, Chairman and Chief Executive of ALR, states, "Without compliance the patient does not receive the intended benefit of treatments and medications, and millions of people are noncompliant with disease management activities. The health insurance industry is now recognizing the opportunity to better manage patient outcome and healthcare costs with enhanced compliance. Given our development progress and ongoing discussions and negotiations with prospective customers, we are optimistic about our sales and earnings projections for 2006."

ALR, a leader in disease management compliance and telehealth, has designed and manufactures compliance reminder products and compliance home-monitoring and intervention systems to meet the needs for several targeted user groups. Compliance reminder products are now in use by patients taking medications or treatments for conditions such as hypertension, high cholesterol, Parkinson, diabetes, organ transplant, depression, anxiety, asthma, glaucoma and more. More information on ALR Technologies and its products can be found at

This release contains certain "forward-looking statements" relating to ALR Tech's business, and these statements reflect the current views of ALR Tech with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "optimistic," "projections," "plan to," "estimate," "expect," "anticipate," "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Tech and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange Commission.

Contact Information

  • For more information, please contact:

    For ALR Technologies Inc.:
    Stan Cruitt
    336-722-2254 Ext. 5
    email: Email Contact